CRISPR/Cas9 Editing of the Mouse Thra Gene Produces Models with Variable Resistance to Thyroid Hormone

Suzy Markossian1, Romain Guyot1, Sabine Richard1

  • 11 Institut de Génomique Fonctionnelle de Lyon, Université de Lyon CNRS UMR 5242, INRA USC 1370, Ecole Normale Supérieure de Lyon , Lyon, France .

Abstract

Insights

New mouse models reveal how thyroid hormone receptor alpha (TRα) mutations cause resistance to thyroid hormone (RTHα), impacting development. Phenotype severity correlates with mutant receptor interactions, aiding future RTHα research.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • Resistance to thyroid hormone alpha (RTHα) is a genetic disorder caused by mutations in the THRA gene.
  • These mutations affect the function of the thyroid hormone receptor alpha 1 (TRα1), a key nuclear receptor involved in thyroid hormone action.

Purpose of the Study:

  • To investigate the genotype-phenotype relationship in RTHα.
  • To develop and characterize novel mouse models for studying RTHα.

Main Methods:

  • Utilized CRISPR/Cas9 genome editing to create five distinct mouse models of RTHα.
  • Generated mouse models with frameshift or missense mutations in the THRA gene.

Main Results:

  • Mutant mice exhibited a hypothyroid-like phenotype and developmental alterations, mirroring human RTHα patients.
  • The severity of the observed phenotype varied among the mouse models.
  • Phenotype severity was linked to the mutant TRα1 receptor's ability to interact with transcription corepressors in a thyroid hormone-dependent manner.

Conclusions:

  • The developed mouse models are highly relevant for studying human RTHα.
  • These models will facilitate future research into the mechanisms and potential treatments for RTHα.